Annis Gardner Whiting Capital Advisors, LLC Arrowhead Pharmaceuticals, Inc. Transaction History
Annis Gardner Whiting Capital Advisors, LLC
- $352 Billion
- Q2 2024
A detailed history of Annis Gardner Whiting Capital Advisors, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Annis Gardner Whiting Capital Advisors, LLC holds 29 shares of ARWR stock, worth $644. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29
Previous 29
-0.0%
Holding current value
$644
Previous $830,000
9.16%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ARWR
# of Institutions
295Shares Held
92.3MCall Options Held
1.33MPut Options Held
549K-
Black Rock Inc. New York, NY15.7MShares$348 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$271 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.89MShares$198 Million3.15% of portfolio
-
State Street Corp Boston, MA5.84MShares$130 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY4.14MShares$92 Million2.11% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $2.35B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...